Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC has intensified oversight of pharmaceuticals and medical devices, issuing alerts on counterfeit products and blacklisting a non-compliant manufacturer, while also promoting public health initiatives. These actions signal stricter enforcement and the need for SMBs in healthcare to enhance supply chain integrity and compliance.
Pharmaceuticals
Medical Devices
Food and Beverages
Import/Export
Healthcare
NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026
NAFDAC
NAFDAC celebrates World Breastfeeding Week 2026, emphasizing the importance of breastfeeding for infant health.
May lead to increased scrutiny of breast milk substitutes and marketing practices; SMBs in baby food/nutrition should ensure compliance with labeling and promotion regulations.
Handling Manufacturer Investigation Reports for Medical Devices and IVDs
NAFDAC
NAFDAC provides guidance on handling Manufacturer Investigation Reports (MIRs) for medical devices and IVDs, focusing on complaint and adverse event assessment.
Medical device and IVD manufacturers and importers must establish robust MIR procedures to ensure timely reporting and risk management.
Blacklisting of Onifam Laboratories Ltd
NAFDAC
NAFDAC blacklists Onifam Laboratories Ltd and associated entities from pharmaceutical business activities due to regulatory misrepresentation and improper use of approvals.
SMBs in pharmaceutical distribution must verify the compliance status of suppliers and partners to avoid association with blacklisted entities.
Public Alert No. 037/2026 – Alert on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension
NAFDAC
NAFDAC alerts the public to suspected counterfeit Pulmicort® (Budesonide) inhalation suspension in the market, infringing on AstraZeneca's approval.
Pharmacies and distributors must verify product authenticity and report suspicious items; SMBs should enhance anti-counterfeiting measures.
Public Alert No. 036/2026 – Alert on Suspected Counterfeit Products Mimicking Forxiga® (Dapagliflozin)
NAFDAC
NAFDAC warns of suspected counterfeit Forxiga® (dapagliflozin) products in Nigeria, infringing on AstraZeneca's marketing authorization.
Healthcare providers and SMBs in pharma must be vigilant in sourcing genuine products and reporting counterfeits.
SON rides on e-platform to facilitate international trade - Business News Nigeria
Other
SON leverages an electronic platform to streamline international trade processes.
SMBs involved in import/export should explore SON's e-platform for faster and more transparent compliance procedures.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
A guide on registering fish farms with NEPC for export purposes.
Fish farmers and exporters should follow NEPC registration guidelines to access export opportunities and comply with trade regulations.
Increased enforcement against counterfeit pharmaceuticals and non-compliant manufacturers.
Emphasis on proper handling of medical device investigations and reporting.
Potential for stricter import/export procedures and digitalization of trade facilitation.
Opportunities for SMBs to enhance compliance and gain consumer trust.
1
Verify the authenticity of pharmaceutical products and maintain traceability records.
2
Establish or update procedures for handling Manufacturer Investigation Reports (MIRs) for medical devices.
3
Screen all suppliers and partners against NAFDAC blacklists and regulatory alerts.
4
Leverage SON's e-platform for trade documentation and compliance.
5
Register with NEPC if involved in fish farming or export to ensure compliance and market access.